Association of human T lymphotropic virus type I with Sjögren syndrome

Annals of the Rheumatic Diseases

Volumn 69, Issue 11, 2010, Pages 2056-2057

  Hida, Ayumi ^a   Imaizumi, Misa ^a   Sera, Nobuko ^a   Akahoshi, Masazumi ^a   Soda, Midori ^a   Maeda, Renju ^a   Nakashima, Eiji ^a   Nakamura, Hideki ^b   Ida, Hiroaki ^b   Kawakami, Atsushi ^b   Eguchi, Katsumi ^b  

^a RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI SS A ANTIBODY; ANTI SS B ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY PRODUCTION; AUTOIMMUNITY; BOMB; CLINICAL FEATURE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LETTER; NONHUMAN; PRIORITY JOURNAL; SEROPREVALENCE; SJOEGREN SYNDROME; AGED; BLOOD; FEMALE; IMMUNOLOGY; MALE; VIROLOGY;

AGED; ANTIBODIES, VIRAL; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; SJOGREN'S SYNDROME;

EID: 78149488458     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.128736     Document Type: Letter

References (10)

1. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 1994;344:1116-19. (Pubitemid 24317631)
2. Atomic Bomb Casualty Commission. Research Plan for Joint ABCC-NIH Adult Health Study in Hiroshima and Nagasaki, Japan. Hiroshima, Japan: ABCC Technical Report, 1962:11-62.
3. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
4. Hida A, Akahoshi M, Takagi Y, et al. Prevalence of Sjogren syndrome among Nagasaki atomic bomb survivors. Ann Rheum Dis 2008;67:689-95.
5. Yamashita I, Katamine S, Moriuchi R, et al. Transactivation of the human interleukin-6 gene by human T-lymphotropic virus type 1 Tax protein. Blood 1994;84:1573-8.
6. Kawakami A, Nakashima T, Sakai H, et al. Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation. Blood 1999;94:3847-54.
7. Nakamura H, Kawakami A, Hayashi T, et al. Low prevalence of ectopic germinal centre formation in patients with HTLV-I-associated Sjogren's syndrome. Rheumatology (Oxford) 2009;48:854-5.
8. Eguchi K, Matsuoka N, Ida H, et al. Primary Sjögren's syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 1992;51:769-76.
9. Matsuo T, Nakashima E, Carter RL, et al. Anti-Human T-lymphotropic virus type-I antibodies in atomic-bomb survivors. J Radiat Res 1995;36:8-16.
10. Young R, Kerr G, eds. Reassessment of the atomic bomb radiation dosimetry for Hiroshima and Nagasaki - dosimetry system 2002. Hiroshima: Radiation Effects Research Foundation, 2005.